Vivani Medical (VANI) Cost of Revenue (2014 - 2019)
Vivani Medical (VANI) posted quarterly Cost of Revenue of $124000.0 for Q4 2019, down 92.25% year-over-year from $1.6 million in Q4 2018, and down 65.93% quarter-over-quarter from $364000.0 in Q3 2019.
Vivani Medical (VANI) Cost of Revenue (2014 - 2019) Analysis & Trends
Vivani Medical's Cost of Revenue history runs 6 years deep, the most recent figure standing at $124000.0 for Q4 2019.
- In Q4 2019, Cost of Revenue fell 92.25% year-over-year to $124000.0; the TTM figure through Jun 2021 stood at $488000.0 (down 65.66% YoY), while the FY2021 annual figure was $130000.0, down 74.0% from the prior year.
- Cost of Revenue for Q4 2019 stood at $124000.0, down from $364000.0 in the prior quarter.
- The five-year high for Cost of Revenue was $3.3 million in Q4 2016, with the low at $124000.0 in Q4 2019.
- The 5-year median for Cost of Revenue is $1.1 million (2017), against an average of $1.4 million.
- The sharpest annual moves came in 2016 and 2019: Cost of Revenue soared 245.4% in 2016, then sank 92.25% in 2019.
- Vivani Medical's Cost of Revenue stood at $1.7 million in 2015, then jumped by 97.99% to $3.3 million in 2016, then tumbled by 43.71% to $1.9 million in 2017, then fell by 14.02% to $1.6 million in 2018, then tumbled by 92.25% to $124000.0 in 2019.
- Business Quant data shows VANI's Cost of Revenue at $124000.0 in Q4 2019, $364000.0 in Q3 2019, and $933000.0 in Q2 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 489.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 360.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 145.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 93.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 174.53 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 298.26 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 387.98 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 67.21 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Vivani Medical | 120.18 Mn | 100.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 124,000.00 |
| Dec 31, 2019 | 124,000.00 |
| Sep 30, 2019 | 364,000.00 |
| Sep 30, 2019 | 364,000.00 |
| Jun 30, 2019 | 933,000.00 |
| Jun 30, 2019 | 933,000.00 |
| Mar 31, 2019 | 731,000.00 |
| Mar 31, 2019 | 731,000.00 |
| Dec 31, 2018 | 1.60 Mn |
| Dec 31, 2018 | 1.60 Mn |
| Sep 30, 2018 | 1.78 Mn |
| Sep 30, 2018 | 1.78 Mn |
| Jun 30, 2018 | 836,000.00 |
| Jun 30, 2018 | 836,000.00 |
| Mar 31, 2018 | 668,000.00 |
| Mar 31, 2018 | 668,000.00 |
| Dec 31, 2017 | 1.86 Mn |
| Dec 31, 2017 | 1.86 Mn |
| Sep 30, 2017 | 1.00 Mn |
| Sep 30, 2017 | 1.00 Mn |